665 related articles for article (PubMed ID: 28376824)
1. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: Systematic review and meta-analysis.
Fabrizi F; Dixit V; Martin P; Messa P
J Med Virol; 2016 Mar; 88(3):487-97. PubMed ID: 26271205
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.
Peters L; Grint D; Lundgren JD; Rockstroh JK; Soriano V; Reiss P; Grzeszczuk A; Sambatakou H; Mocroft A; Kirk O;
AIDS; 2012 Sep; 26(15):1917-26. PubMed ID: 22781222
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.
Kalayjian RC; Lau B; Mechekano RN; Crane HM; Rodriguez B; Salata RA; Krishnasami Z; Willig JH; Martin JN; Moore RD; Eron JJ; Kitahata MM
AIDS; 2012 Sep; 26(15):1907-15. PubMed ID: 22824630
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.
Lucas GM; Jing Y; Sulkowski M; Abraham AG; Estrella MM; Atta MG; Fine DM; Klein MB; Silverberg MJ; Gill MJ; Moore RD; Gebo KA; Sterling TR; Butt AA;
J Infect Dis; 2013 Oct; 208(8):1240-9. PubMed ID: 23904290
[TBL] [Abstract][Full Text] [Related]
6. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
Kaboré NF; Poda A; Zoungrana J; Da O; Ciaffi L; Semdé A; Yaméogo I; Sawadogo AB; Delaporte E; Meda N; Limou S; Cournil A
BMC Nephrol; 2019 May; 20(1):155. PubMed ID: 31064340
[TBL] [Abstract][Full Text] [Related]
7. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
Bahirwani R; Barin B; Olthoff K; Stock P; Murphy B; Rajender Reddy K;
Liver Transpl; 2013 Jun; 19(6):619-26. PubMed ID: 23512786
[TBL] [Abstract][Full Text] [Related]
8. Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status.
Marcus JL; Leyden WA; Chao CR; Xu L; Quesenberry CP; Tien PC; Klein DB; Towner WJ; Horberg MA; Silverberg MJ
AIDS Patient Care STDS; 2015 Jul; 29(7):370-8. PubMed ID: 26061798
[TBL] [Abstract][Full Text] [Related]
9. Chronic kidney disease in Australian Human Immunodeficiency Virus-infected patients: Analysis of the Australian HIV Observational Database.
Cheung J; Puhr R; Petoumenos K; Cooper DA; Woolley I; Gunathilake M; Raymond N; Varma R; O'Connor CC; Gracey DM
Nephrology (Carlton); 2018 Aug; 23(8):778-786. PubMed ID: 28703924
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; ; ; ; ;
PLoS Med; 2015 Mar; 12(3):e1001809. PubMed ID: 25826420
[TBL] [Abstract][Full Text] [Related]
11. Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons.
Mocroft A; Ryom L; Oprea C; Li Q; Rauch A; Boesecke C; Uzdaviniene V; Sedlacek D; Llibre JM; Lacombe K; Nielsen LN; Florence E; Aho I; Chkhartishvili N; Szlavik J; Dragovic G; Leen C; Sambatakou H; Staub T; Laguno M; Elinav H; Tomažič J; Peters L;
AIDS; 2020 Aug; 34(10):1485-1495. PubMed ID: 32675562
[TBL] [Abstract][Full Text] [Related]
12. Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort.
Provoost A; Dramé M; Cotte L; Cuzin L; Garraffo R; Rey D; Raffi F; Poizot-Martin I; Pugliese P; Bani-Sadr F;
Aliment Pharmacol Ther; 2018 Aug; 48(3):281-289. PubMed ID: 29901821
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors for chronic kidney disease among HIV-infected antiretroviral therapy-naïve patients in mainland China: a multicenter cross-sectional study.
Cao Y; Gong M; Han Y; Xie J; Li X; Zhang L; Li Y; Song X; Zhu T; Li T
Nephrology (Carlton); 2013 Apr; 18(4):307-12. PubMed ID: 23311442
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES.
Rogal SS; Yan P; Rimland D; Lo Re V; Al-Rowais H; Fried L; Butt AA;
Dig Dis Sci; 2016 Mar; 61(3):930-6. PubMed ID: 26526451
[TBL] [Abstract][Full Text] [Related]
15. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB;
PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666
[TBL] [Abstract][Full Text] [Related]
17. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
Kooij KW; Vogt L; Wit FWNM; van der Valk M; van Zoest RA; Goorhuis A; Prins M; Post FA; Reiss P;
J Infect Dis; 2017 Sep; 216(6):622-631. PubMed ID: 28934420
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.
Mussini C; Lorenzini P; Puoti M; Lichtner M; Lapadula G; Di Giambenedetto S; Antinori A; Madeddu G; Cozzi-Lepri A; d'Arminio Monforte A; De Luca A;
PLoS One; 2015; 10(12):e0140877. PubMed ID: 26640953
[TBL] [Abstract][Full Text] [Related]
19. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
Rasch MG; Engsig FN; Feldt-Rasmussen B; Kirk O; Kronborg G; Pedersen C; Gerstoft J; Obel N
Scand J Infect Dis; 2012 Sep; 44(9):689-96. PubMed ID: 22680981
[TBL] [Abstract][Full Text] [Related]
20. Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study.
Leone S; Shanyinde M; Cozzi Lepri A; Lampe FC; Caramello P; Costantini A; Giacometti A; De Luca A; Cingolani A; Ceccherini Silberstein F; Puoti M; Gori A; d'Arminio Monforte A;
Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):871-881. PubMed ID: 29318459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
